Platelet-rich plasma for articular cartilage repair

Sports Medicine and Arthroscopy Review

Volumn 21, Issue 4, 2013, Pages 213-219

  Abrams, Geoffrey D ^a   Frank, Rachel M ^a   Fortier, Lisa A ^b   Cole, Brian J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Cornell University ^*  (United States)

Author keywords

articular; cartilage; platelet rich plasma; PRP

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; HEALING; HUMAN; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION;

ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CYTOKINES; GUIDED TISSUE REGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOARTHRITIS; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 84888263751     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0b013e3182999740     Document Type: Review

References (44)

1. Perera JR, Jaiswal PK, Khan WS. The potential therapeutic use of stem cells in cartilage repair. Curr Stem Cell Res Ther. 2012;7:149-156
2. Mehta V. Platelet-rich plasma: A review of the science and possible clinical applications. Orthopedics. 2010;33:111
3. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033-1042
4. Paoloni J, De Vos RJ, Hamilton B, et al. Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sport Med. 2011;21:37-45
5. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(suppl 1):S13-S33
6. Solorio LD, Dhami CD, Dang PN, et al. Spatiotemporal regulation of chondrogenic differentiation with controlled delivery of transforming growth factor-beta1 from gelatin microspheres in mesenchymal stem cell aggregates. Stem Cells Transl Med. 2012;1:632-639
7. Park KH, Na K. Effect of growth factors on chondrogenic differentiation of rabbit mesenchymal cells embedded in injectable hydrogels. J Biosci Bioeng. 2008;106:74-79
8. Brandl A, Angele P, Roll C, et al. Influence of the growth factors PDGF-BB, TGF-beta1 and bFGF on the replicative aging of human articular chondrocytes during in vitro expansion. J Orthop Res. 2010;28:354-360
9. Boswell SG, Cole BJ, Sundman EA, et al. Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy. 2012;28:429-439
10. Daheshia M, Yao JQ. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J Rheumatol. 2008;35:2306-2312
11. Chen LX, Lin L, Wang HJ, et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage. 2008;16:174-184
12. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum. 2009;60:2037-2045
13. Pola E, Papaleo P, Pola R, et al. Interleukin-6 gene polymorphism and risk of osteoarthritis of the hip: A casecontrol study. Osteoarthritis Cartilage. 2005;13:1025-1028
14. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344-362
15. Basak S, Kim H, Kearns JD, et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 2007;128: 369-381
16. Bode JG, Albrecht U, Haussinger D, et al. Hepatic acute phase proteins - regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur J Cell Biol. 2012;91:496-505
17. Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 1996;39:1535-1544
18. Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52:128-135
19. Pereira RC, Scaranari M, Benelli R, et al. Dual effect of platelet lysate on human articular cartilage: A maintenance of chondrogenic potential and a transient pro-inflammatory activity followed by an inflammation resolution. Tissue Eng Part A. 2013;19:1476-1488
20. van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011;39:2362-2370
21. Kruger JP, Hondke S, Endres M, et al. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J Orthop Res. 2012;30:845-852
22. Park SI, Lee HR, Kim S, et al. Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures. Mol Cell Biochem. 2012; 361:9-17
23. Woodell-May J, Matuska A, Oyster M, et al. Autologous protein solution inhibits MMP-13 production by IL-1beta and TNFalpha-stimulated human articular chondrocytes. J Orthop Res. 2011;29:1320-1326
24. Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-kappaB inhibition via HGF. J Cell Physiol. 2010;225:757-766
25. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006;14:1272-1280
26. Xie X, Wang Y, Zhao C, et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRPderived scaffold for cartilage regeneration. Biomaterials. 2012; 33:7008-7018
27. Mishra A, Tummala P, King A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods. 2009;15:431-435
28. Browning SR, Weiser AM, Woolf N, et al. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. J Bone Joint Surg Am. 2012;94:e1721-e1727
29. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage. 2000;8:309-334
30. Fortier LA, Hackett CH, Cole BJ. The effects of platelet-rich plasma on cartilage: Basic science and clinical application. Op Tech Sports Med. 2011;19:154-159
31. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011; 39:2135-2140
32. Brehm W, Aklin B, Yamashita T, et al. Repair of superficial osteochondral defects with an autologous scaffold-free cartilage construct in a caprine model: Implantation method and short-term results. Osteoarthritis Cartilage. 2006;14:1214-1226
33. Sun Y, Feng Y, Zhang CQ, et al. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010;34:589-597
34. Milano G, Sanna Passino E, Deriu L, et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: An experimental study in a sheep model. Osteoarthritis Cartilage. 2010;18:971-980
35. Kon E, Filardo G, Delcogliano M, et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord. 2010;11:220
36. Saito M, Takahashi KA, Arai Y, et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol. 2009;27:201-207
37. Serra CI, Soler C, Carillo JM, et al. Effect of autologous platelet-rich plasma on the repair of full-thickness articular defects in rabbits. Knee Surg Sports Traumatol Arthrosc. 2012. [Epub ahead o print
38. Sanchez M, Anitua E, Azofra J, et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study. Clin Exp Rheumatol. 2008;26:910-913
39. Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: Intraarticular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18:472-479
40. Sampson S, Reed M, Silvers H, et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: A pilot study. Am J Phys Med Rehabil. 2010;89: 961-969
41. Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy. 2011;27: 1490-1501
42. Filardo G, Kon E, Buda R, et al. Platelet-rich plasma intraarticular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2011;19:528-535
43. Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial. Am J Sports Med. 2013;41:356-364
44. Haleem AM, Singergy AA, Sabry D, et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: A pilot study and preliminary results. Cartilage. 2010;1:253-261